Login

Switch On Your HIV Smarts.

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

No Link Between Efavirenz and Neurocognitive Impairment in Italian Study

, by San Francisco AIDS Foundation

Efavirenz was in the clear, but what other factors were linked with neurocognitive impairment in this study? Find out in this report from AIDS 2014. Read More

AIDS 2014 Sneak Preview

AIDS 2014 Sneak Preview

, by San Francisco AIDS Foundation

What’s in store at AIDS 2014? Here’s a sneak peek at the most anticipated topics at the 20th International AIDS Conference, starting next week in Melbourne. Read More

Ask A Pharmacist: The ART of Pharmacogenomics and Personalized Medicine

Ask A Pharmacist: The ART of Pharmacogenomics and Personalized Medicine

, by Jennifer Cocohoba, PharmD, AAHIVE

Are you nervous about starting HIV meds because of side effects? See how blood tests can help you figure out beforehand which drugs will work best for you. Read More

A Breakthrough Moment in AIDS History

A Breakthrough Moment in AIDS History

, by San Francisco AIDS Foundation

Twenty-five years ago today, Peter Staley and fellow activists stormed a conference and announced a new agenda for research on life-saving HIV/AIDS treatments. See how their words changed AIDS history. Read More

Rilpivirine Linked with Less Blood Fat Elevation than Efavirenz

Rilpivirine Linked with Less Blood Fat Elevation than Efavirenz

, by San Francisco AIDS Foundation

New research links rilpivirine with significantly smaller elevations in blood fats. What do these findings mean for heart disease risk in people with HIV? Read More